Leonard Greenstein

Leonard Greenstein

Chief Financial OfficeratTarsus Pharmaceuticals· In the 2023 proxy

Pay in FY2023Tarsus Pharmaceuticals stock +38.1% the same year

Leonard Greenstein was paid $2.0M in FY2023 (Dec). Tarsus Pharmaceuticals stock rose 38.1% that year.

Pay$100 in the stock at the end of FY22 → $138
Pay is from the Summary Compensation Table of each Tarsus Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tarsus PharmaceuticalsPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role +407%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?